These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 39068001)

  • 21. Characteristics of gut microbiota and metabolomic of Hainan Tunchang pigs at various growth stages.
    Tan Z; Li J; He Y; Wang F; Xiao Q
    Gene; 2024 Mar; 900():148161. PubMed ID: 38219876
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gut microbial metabolites as multi-kingdom intermediates.
    Krautkramer KA; Fan J; Bäckhed F
    Nat Rev Microbiol; 2021 Feb; 19(2):77-94. PubMed ID: 32968241
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Does the Gut Microbiota Modulate Host Physiology through Polymicrobial Biofilms?
    Yang J; Yang Y; Ishii M; Nagata M; Aw W; Obana N; Tomita M; Nomura N; Fukuda S
    Microbes Environ; 2020; 35(3):. PubMed ID: 32624527
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Implication of gut microbiota metabolites in cardiovascular and metabolic diseases.
    Brial F; Le Lay A; Dumas ME; Gauguier D
    Cell Mol Life Sci; 2018 Nov; 75(21):3977-3990. PubMed ID: 30101405
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multi-omic analysis of host-microbial interactions central to the gut-brain axis.
    Simpson JB; Redinbo MR
    Mol Omics; 2022 Dec; 18(10):896-907. PubMed ID: 36169030
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Microbiome-Metabolomics Analysis of the Impacts of
    Wang L; Cao L; Chang Y; Fu Y; Wang Y; Zhang K; Zhang S; Zhang L
    Microbiol Spectr; 2023 Feb; 11(1):e0217522. PubMed ID: 36533947
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetic Engineering of Resident Bacteria in the Gut Microbiome.
    Arnold J; Glazier J; Mimee M
    J Bacteriol; 2023 Jul; 205(7):e0012723. PubMed ID: 37382533
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The gut microbiota and its interactions with cardiovascular disease.
    Xu H; Wang X; Feng W; Liu Q; Zhou S; Liu Q; Cai L
    Microb Biotechnol; 2020 May; 13(3):637-656. PubMed ID: 31984651
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fecal 16S rRNA sequencing and multi-compartment metabolomics revealed gut microbiota and metabolites interactions in APP/PS1 mice.
    Cheng X; Tan Y; Li H; Huang J; Zhao D; Zhang Z; Yi M; Zhu L; Hui S; Yang J; Peng W
    Comput Biol Med; 2022 Dec; 151(Pt A):106312. PubMed ID: 36417828
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gut microbiota signatures in cystic fibrosis: Loss of host CFTR function drives the microbiota enterophenotype.
    Vernocchi P; Del Chierico F; Russo A; Majo F; Rossitto M; Valerio M; Casadei L; La Storia A; De Filippis F; Rizzo C; Manetti C; Paci P; Ercolini D; Marini F; Fiscarelli EV; Dallapiccola B; Lucidi V; Miccheli A; Putignani L
    PLoS One; 2018; 13(12):e0208171. PubMed ID: 30521551
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gut Microbiota as Important Mediator Between Diet and DNA Methylation and Histone Modifications in the Host.
    D'Aquila P; Carelli LL; De Rango F; Passarino G; Bellizzi D
    Nutrients; 2020 Feb; 12(3):. PubMed ID: 32106534
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gut-microbiota derived bioactive metabolites and their functions in host physiology.
    Debnath N; Kumar R; Kumar A; Mehta PK; Yadav AK
    Biotechnol Genet Eng Rev; 2021 Oct; 37(2):105-153. PubMed ID: 34678130
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Impact of Dietary Fiber on Gut Microbiota in Host Health and Disease.
    Makki K; Deehan EC; Walter J; Bäckhed F
    Cell Host Microbe; 2018 Jun; 23(6):705-715. PubMed ID: 29902436
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Does our gut microbiome predict cardiovascular risk? A review of the evidence from metabolomics.
    Griffin JL; Wang X; Stanley E
    Circ Cardiovasc Genet; 2015 Feb; 8(1):187-91. PubMed ID: 25691688
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Microbial metabolites as modulators of host physiology.
    Joyce SA; Clarke DJ
    Adv Microb Physiol; 2024; 84():83-133. PubMed ID: 38821635
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Gut Microbial Bile Acid Modulation and Its Relevance to Digestive Health and Diseases.
    Fogelson KA; Dorrestein PC; Zarrinpar A; Knight R
    Gastroenterology; 2023 Jun; 164(7):1069-1085. PubMed ID: 36841488
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gut Microbiota and Nonalcoholic Fatty Liver Disease: Insights on Mechanism and Application of Metabolomics.
    He X; Ji G; Jia W; Li H
    Int J Mol Sci; 2016 Mar; 17(3):300. PubMed ID: 26999104
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Microbial metabolites as modulators of the infant gut microbiome and host-microbial interactions in early life.
    Roager HM; Stanton C; Hall LJ
    Gut Microbes; 2023; 15(1):2192151. PubMed ID: 36942883
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Production of Psychoactive Metabolites by Gut Bacteria.
    Wiley NC; Cryan JF; Dinan TG; Ross RP; Stanton C
    Mod Trends Psychiatry; 2021; 32():74-99. PubMed ID: 34032647
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gut Microbiota and Short Chain Fatty Acids: Implications in Glucose Homeostasis.
    Portincasa P; Bonfrate L; Vacca M; De Angelis M; Farella I; Lanza E; Khalil M; Wang DQ; Sperandio M; Di Ciaula A
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163038
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.